63 related articles for article (PubMed ID: 33724863)
1. The results of multigene panel sequencing in Slovak HBOC families.
Konecny M; Kosova K; Tilandyova P; Wachsmannova L; Baldovic M; Krajcovic J; Patlevicova A; Markus J; Ciernikova S
Neoplasma; 2021 May; 68(3):652-664. PubMed ID: 33724863
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario.
de Freitas Ribeiro AA; Junior NMC; Dos Santos LL
Eur J Med Res; 2024 Mar; 29(1):187. PubMed ID: 38504328
[TBL] [Abstract][Full Text] [Related]
3. A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.
Mucaki EJ; Caminsky NG; Perri AM; Lu R; Laederach A; Halvorsen M; Knoll JH; Rogan PK
BMC Med Genomics; 2016 Apr; 9():19. PubMed ID: 27067391
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility.
Quezada Urban R; Díaz Velásquez CE; Gitler R; Rojo Castillo MP; Sirota Toporek M; Figueroa Morales A; Moreno García O; García Esquivel L; Torres Mejía G; Dean M; Delgado Enciso I; Ochoa Díaz López H; Rodríguez León F; Jan V; Garzón Barrientos VH; Ruiz Flores P; Espino Silva PK; Haro Santa Cruz J; Martínez Gregorio H; Rojas Jiménez EA; Romero Cruz LE; Méndez Catalá CF; Álvarez Gómez RM; Fragoso Ontiveros V; Herrera LA; Romieu I; Terrazas LI; Chirino YI; Frecha C; Oliver J; Perdomo S; Vaca Paniagua F
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30262796
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of disease-causing genes in Japanese patients with
Kaneyasu T; Mori S; Yamauchi H; Ohsumi S; Ohno S; Aoki D; Baba S; Kawano J; Miki Y; Matsumoto N; Nagasaki M; Yoshida R; Akashi-Tanaka S; Iwase T; Kitagawa D; Masuda K; Hirasawa A; Arai M; Takei J; Ide Y; Gotoh O; Yaguchi N; Nishi M; Kaneko K; Matsuyama Y; Okawa M; Suzuki M; Nezu A; Yokoyama S; Amino S; Inuzuka M; Noda T; Nakamura S
NPJ Breast Cancer; 2020; 6():25. PubMed ID: 32566746
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer as a sentinel for hereditary cancer predisposition.
Young EL; Thompson BA; Neklason DW; Firpo MA; Werner T; Bell R; Berger J; Fraser A; Gammon A; Koptiuch C; Kohlmann WK; Neumayer L; Goldgar DE; Mulvihill SJ; Cannon-Albright LA; Tavtigian SV
BMC Cancer; 2018 Jun; 18(1):697. PubMed ID: 29945567
[TBL] [Abstract][Full Text] [Related]
7. Targeted sequencing for hereditary breast and ovarian cancer in BRCA1/2-negative families from the Lynch Memorial Biobank reveals complex genetic architecture and phenocopies.
Plowman JN; Matoy EJ; Uppala LV; Draves SB; Watson CJ; Sefranek BA; Stacey ML; Anderson SP; Belshan MA; Blue EE; Huff CD; Fu Y; Stessman HAF
HGG Adv; 2024 May; ():100306. PubMed ID: 38734904
[TBL] [Abstract][Full Text] [Related]
8. Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology.
Malhotra H; Kowtal P; Mehra N; Pramank R; Sarin R; Rajkumar T; Gupta S; Bapna A; Bhattacharyya GS; Gupta S; Maheshwari A; Mannan AU; Reddy Kundur R; Sekhon R; Singhal M; Smruti BK; Sp S; Suryavanshi M; Verma A
JCO Glob Oncol; 2020 Jul; 6():991-1008. PubMed ID: 32628584
[TBL] [Abstract][Full Text] [Related]
9. EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.
McDevitt T; Durkie M; Arnold N; Burghel GJ; Butler S; Claes KBM; Logan P; Robinson R; Sheils K; Wolstenholme N; Hanson H; Turnbull C; Hume S
Eur J Hum Genet; 2024 May; 32(5):479-488. PubMed ID: 38443545
[TBL] [Abstract][Full Text] [Related]
10. The Genetic Paradigm of Hereditary Breast and Ovarian Cancer (HBOC) in the Afro-Caribbean Population.
Cerbon D; Taylor D; Barreto-Coelho P; Rodriguez E; Schlumbrecht M; Hurley J; George SHL
Crit Rev Oncog; 2024; 29(3):99-112. PubMed ID: 38683157
[TBL] [Abstract][Full Text] [Related]
11. Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
Nielsen SM; Eccles DM; Romero IL; Al-Mulla F; Balmaña J; Biancolella M; Bslok R; Caligo MA; Calvello M; Capone GL; Cavalli P; Chan TLC; Claes KBM; Cortesi L; Couch FJ; de la Hoya M; De Toffol S; Diez O; Domchek SM; Eeles R; Efremidis A; Fostira F; Goldgar D; Hadjisavvas A; Hansen TVO; Hirasawa A; Houdayer C; Kleiblova P; Krieger S; Lázaro C; Loizidou M; Manoukian S; Mensenkamp AR; Moghadasi S; Monteiro AN; Mori L; Morrow A; Naldi N; Nielsen HR; Olopade OI; Pachter NS; Palmero EI; Pedersen IS; Piane M; Puzzo M; Robson M; Rossing M; Sini MC; Solano A; Soukupova J; Tedaldi G; Teixeira M; Thomassen M; Tibiletti MG; Toland A; Törngren T; Vaccari E; Varesco L; Vega A; Wallis Y; Wappenschmidt B; Weitzel J; Spurdle AB; De Nicolo A; Gómez-García EB
JCO Precis Oncol; 2018; 2():. PubMed ID: 31517176
[TBL] [Abstract][Full Text] [Related]
12. Optical Genome Mapping Reveals the Landscape of Structural Variations and Their Clinical Significance in HBOC-Related Breast Cancer.
Cheng Y; Dong L; Bu D; Han L; Zhao Y; Liu J; Guo X; Xu H; Yu J
Front Biosci (Landmark Ed); 2024 Jan; 29(1):2. PubMed ID: 38287797
[TBL] [Abstract][Full Text] [Related]
13. [Return of Individual Genomic Results to Germline Pathogenic Variant Carriers of Hereditary Cancer in Population Based Cohort Study].
Ohneda K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):231-236. PubMed ID: 38494798
[TBL] [Abstract][Full Text] [Related]
14. Search Behavior Regarding Cancer Susceptibility Genes Using a Clinical Decision Support Tool for Gene-Specific Penetrance: Content Analysis.
Yin K; Zhou J; Singh P; Wang J; Braun D; Hughes KS
JMIR Cancer; 2021 Jul; 7(3):e28527. PubMed ID: 34255640
[TBL] [Abstract][Full Text] [Related]
15. Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers.
McAlarnen L; Stearns K; Uyar D
Appl Clin Genet; 2021; 14():1-9. PubMed ID: 33488111
[TBL] [Abstract][Full Text] [Related]
16. Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.
Ben Ayed-Guerfali D; Ben Kridis-Rejab W; Ammous-Boukhris N; Ayadi W; Charfi S; Khanfir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
J Transl Med; 2021 Mar; 19(1):108. PubMed ID: 33726785
[TBL] [Abstract][Full Text] [Related]
17. New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients.
Gervas P; Molokov A; Ivanova A; Panferova Y; Kiselev A; Chernyshova A; Pisareva L; Choynzonov E; Cherdyntseva N
Exp Oncol; 2021 Mar; 43(1):52-55. PubMed ID: 33785725
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of
Fujisawa F; Tamaki Y; Inoue T; Nakayama T; Yagi T; Kittaka N; Yoshinami T; Nishio M; Matsui S; Kusama H; Kamiura S
Mol Clin Oncol; 2021 May; 14(5):96. PubMed ID: 33767865
[TBL] [Abstract][Full Text] [Related]
19. Familial pancreatic cancer: who should be considered for genetic testing?
Kartal K; Guan Z; Tang R; Griffin M; Wang Y; Braun D; Klein AP; Hughes KS
Ir J Med Sci; 2022 Apr; 191(2):641-650. PubMed ID: 33733397
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in
Hu L; Su L; Cheng H; Mo C; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Zhang J; Xie Y
Cancer Res; 2021 May; 81(10):2600-2611. PubMed ID: 33727227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
